Raylumis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Raylumis, covering 2022-02-15 to 2022-02-15. Get the full timeline:
Most recent: EMA Refused: Raylumis (tanezumab) — Pfizer Europe MA EEIG
1 regulatory and trial event tracked for Raylumis, covering 2022-02-15 to 2022-02-15. Get the full timeline:
Most recent: EMA Refused: Raylumis (tanezumab) — Pfizer Europe MA EEIG